Capital International Sarl’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Sell
2,800
-2,488
-47% -$451K 0.01% 256
2026
Q1
$705K Sell
5,288
-1,717
-25% -$273K 0.01% 242
2025
Q4
$1.22M Hold
7,005
– – 0.02% 231
2025
Q3
$1.34M Buy
7,005
+1,179
+20% +$217K 0.02% 222
2025
Q2
$1.74M Sell
5,826
-35
-0.6% -$11K 0.03% 210
2025
Q1
$1.93M Buy
5,861
+2,136
+57% +$645K 0.04% 199
2024
Q4
$1.08M Buy
3,725
+1,233
+49% +$381K 0.03% 224
2024
Q3
$859K Buy
2,492
+405
+19% +$134K 0.02% 227
2024
Q2
$620K Buy
2,087
+527
+34% +$179K 0.02% 230
2024
Q1
$641K Buy
1,560
+907
+139% +$351K 0.02% 213
2023
Q4
$236K Hold
653
– – 0.01% 221
2023
Q3
$214K Sell
653
-230
-26% -$72.4K 0.01% 219
2023
Q2
$266K Hold
883
– – 0.01% 221
2023
Q1
$236K Buy
+883
New +$254K 0.01% 223

Other funds holding MOH

Capital International Sarl's MOH Position: Q2 2026 in Review

Capital International Sarl reduced its Molina Healthcare (MOH) stake by 47% in Q2 2026, selling an estimated $451K and leaving 2,800 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #256.

Capital International Sarl first reported a position in MOH in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.93M in Q1 2025. 602 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Capital International Sarl held 2,800 shares of Molina Healthcare worth $640K as of Q2 2026.
  • Capital International Sarl sold 2,488 Molina Healthcare shares in Q2 2026, an estimated $451K.
  • Molina Healthcare made up 0.01% of Capital International Sarl's portfolio in Q2 2026, its #256 holding.
  • Capital International Sarl first reported a position in Molina Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Capital International Sarl's Molina Healthcare position peaked at $1.93M in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.